Research-grade Dulaglutide. Long-acting GLP-1 Fc-fusion research compound for weekly-administration protocol studies.

Dulaglutide is a GLP-1 Fc-fusion research compound — two GLP-1 analog molecules covalently linked to a human IgG4 Fc fragment. This fusion architecture produces an extremely long half-life suitable for weekly research administration.
The Fc fusion design provides Dulaglutide with FcRn-mediated recycling, dramatically extending half-life to approximately 5 days. The GLP-1 portion retains receptor-binding activity while the Fc fragment confers prolonged systemic exposure.
Used in research investigating: long-acting peptide pharmacokinetics, Fc-fusion design principles, comparative metabolic studies vs daily/weekly GLP-1 analogs.
| Compound | Dulaglutide |
| Available Strengths | 5mg, 10mg |
| Purity | ≥99% (verified by HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Reconstitution | Bacteriostatic water (sold separately) |
| Shelf Life | 36 months (lyophilized, properly stored) |
| Certificate of Analysis | Available upon request — contact us |
Add bacteriostatic water slowly. Use within 28 days.
Lyophilized: -20°C. Reconstituted: 2-8°C.
For research use only. Not for human consumption.